Phentermine and topiramate for the management of obesity: a review.

about

Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models Current and cutting-edge interventions for the treatment of obese patients.New avatars in endocrine practice: The bariatric physician.

P2860

Q34286437-44F28B31-5AC7-4A8E-9820-291095F2881D Q38698582-673CF3A7-76AE-4C03-80D6-CC7C6E44C813 Q42776093-3418F125-B62C-4E6D-99A0-2BFD6F77E2CC

P2860

Phentermine and topiramate for the management of obesity: a review.

Item

http://www.wikidata.org/entity/Q36758207

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Phentermine and topiramate for the management of obesity: a review.

@ast

Phentermine and topiramate for the management of obesity: a review.

@en

type

Item

label

Phentermine and topiramate for the management of obesity: a review.

@ast

Phentermine and topiramate for the management of obesity: a review.

@en

prefLabel

Phentermine and topiramate for the management of obesity: a review.

@ast

Phentermine and topiramate for the management of obesity: a review.

@en

P1476

Phentermine and topiramate for the management of obesity: a review.

@en

P2093

Ariane O Conrad

http://www.w3.org/2001/XMLSchema#string

Gabriel I Uwaifo

http://www.w3.org/2001/XMLSchema#string

Gina Cosentino

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacotherapies for obesity: past, current, and future therapies

Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

Effects of torcetrapib in patients at high risk for coronary events

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.

Combination drugs for treating obesity.

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

Meta-analysis: pharmacologic treatment of obesity.

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

Current and future drug targets in weight management

P304

267-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S31443

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23630412

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

Adipositas

amine

P932

3623549

http://www.w3.org/2001/XMLSchema#string

Phentermine and topiramate for the management of obesity: a review.

about

P2860

P2860

Phentermine and topiramate for the management of obesity: a review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932